For the Inventor, By the Inventor

Enter assignee name

Cambridge, United Kingdom

F-star Therapeutics, Inc.

USPTO Granted Patents = 11

EPO Patents = 3

Trademarks = 3

Forward Citations = 42

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Mihriban Tuna (5 out of 14 patents)

Radhakrishnan P Iyer (4 out of 37 patents)

Francisca Wollerton Van Horck (3 out of 5 patents)

4. Anjaneyulu Sheri (3 out of 5 patents)

5. Geeta Meher (3 out of 5 patents)

6. Shenghua Zhou (3 out of 8 patents)

7. Sreerupa Challa (3 out of 6 patents)

8. Katy Louise Everett (2 out of 4 patents)

9. Miguel Gaspar (2 out of 5 patents)

10. Katarzyna Kmiecik (2 out of 3 patents)

11. Matthew Kraman (2 out of 3 patents)

12. Natalie Fosh (2 out of 3 patents)

13. Mustapha Faroudi (2 out of 3 patents)

14. Florian Ruker (2 out of 13 patents)

15. Gordana Wozniak-Knopp (2 out of 12 patents)

11 patents: Sort by Forward Citations

1. 12312408 - Multispecific anti-TCR delta variable 1 antibodies (2025-05-27),

2. 11827720 - Multivalent immunoglobulins (2023-11-28),

3. 11744845 - Compounds,compositions, and methods for the treatment of disease (2023-09-05),

4. 11707531 - Compounds, compositions, and methods for the treatment of disease (2023-07-25),

5. 11638716 - Compounds, compositions, and methods for the treatment of disease (2023-05-02),

6. 11629193 - EGFR binding molecules (2023-04-18),

7. 11584774 - Compounds, compositions, and methods for the treatment of disease (2023-02-21),

8. 11548948 - FC binding fragments comprising a PD-L1 antigen-binding site (2023-01-10),

9. 11499249 - Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions (2022-11-15),

10. 11214620 - Binding molecules binding PD-L1 and LAG-3 (2022-01-04),

11. 11214618 - LAG-3 binding members (2022-01-04),

F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a novel class of immuno-oncology bispecific antibody products designed to target the tumor microenvironment. Their proprietary technology platform enables the development of highly potent and specific bispecific antibodies for the treatment of cancer and other diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

11 Patents

#82 in Cambridge

#1,562 in United Kingdom

#50,238 in the World

Cambridge, United Kingdom

F-star Therapeutics, Inc.

Forward Citations = 42

33 inventors:

Mihriban Tuna (5 out of 14 patents)

Radhakrishnan P Iyer (4 out of 37 patents)

Francisca Wollerton Van Horck (3 out of 5 patents)

4. Anjaneyulu Sheri (3 out of 5 patents)

5. Geeta Meher (3 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…